Evidence map›Paper›PMID 24154599›Full record

ArticleScience translational medicine2013

Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry.

Amir Horowitz, Dara M Strauss-Albee, Michael Leipold, Jessica Kubo, Neda Nemat-Gorgani, Ozge C Dogan, Cornelia L Dekker, Sally Mackey, Holden Maecker, Gary E Swan and 6 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Science translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 363 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
363citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01987349 phase4completednot on this map

Protective Mechanisms Against a Pandemic Respiratory Virus: B- Cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 1, 2009

TypeinterventionalSponsorStanford UniversityRan2009 to 2010Enrolled72ConditionsInfluenzaArmsFluzone® (intramuscular), FluMist® (intranasal)
NCT03022396 phase4completednot on this map

Protective Mechanisms Against a Pandemic Respiratory Virus: B- Cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 2, 2010

TypeinterventionalSponsorStanford UniversityRan2010 to 2011Enrolled82ConditionsInfluenzaArmsHigh Dose Fluzone® (intramuscular), Fluzone® (intramuscular)
3 · Its place in the literature

Who cites it

363 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The Role of Heme Oxygenase-1 Promoter Polymorphisms in Perinatal Disease.International journal of environmental research and public health · 2021
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

303 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Amir HorowitzDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Dara M Strauss-Albee
Michael Leipold
Jessica Kubo
Neda Nemat-Gorgani
Ozge C Dogan
Cornelia L Dekker
Sally Mackey
Holden Maecker
Gary E Swan
Mark M Davis
Paul J Norman
Lisbeth A Guethlein
Manisha Desai
Peter Parham
Catherine A Blish

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Therapeutic Potential of Adaptive NK Cells in Cancer and TransplantationP01CA111412 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MILLER, JEFFREY S. · 2005 to 2025
$38.2M
Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4M
Vaccination and infection: indicators of immunological health and responsivenessU19AI090019 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 2010 to 2015
$17.3M
INTERACTIONS BETWEEN HLA CLASS I &CYTOLYTIC LYMPHOCYTESR01AI022039 · NIAID · STANFORD UNIVERSITY · PI PARHAM, PETER R · 1985 to 2017
$5.2M
PHARMACOKINETICS OF NICOTINE IN TWINSR01DA011170 · NIDA · SRI INTERNATIONAL · PI SWAN, GARY E · 1998 to 2002
$1.5M
Opioid Efficacy In Humans: A Twin StudyR01DA023063 · NIDA · STANFORD UNIVERSITY · PI ANGST, MARTIN STEPHAN, CLARK, DAVID J. · 2008 to 2010
$1.4M
Effects of Tobacco Exposure on Immune ResponsesR21ES022153 · NIEHS · STANFORD UNIVERSITY · PI NADEAU, KARI C. · 2013 to 2014
$471k
NCATS NIH HHS UL1 TR001085NCI NIH HHS P01 CA111412NCRR NIH HHS UL1 RR025744NIAID NIH HHS AI057229NIAID NIH HHS AI090019NIAID NIH HHS AI22039NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI022039NIAID NIH HHS T32 AI007290NIAID NIH HHS T32 AI07290NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI090019NIAID NIH HHS U19AI090019NIDA NIH HHS DA011170NIDA NIH HHS DA023063NIDA NIH HHS R01 DA011170NIDA NIH HHS R01 DA023063NIEHS NIH HHS ES022153NIEHS NIH HHS R21 ES022153
6 · The paper itself

Abstract

Natural killer (NK) cells play critical roles in immune defense and reproduction, yet remain the most poorly understood major lymphocyte population. Because their activation is controlled by a variety of combinatorially expressed activating and inhibitory receptors, NK cell diversity and function are closely linked. To provide an unprecedented understanding of NK cell repertoire diversity, we used mass cytometry to simultaneously analyze 37 parameters, including 28 NK cell receptors, on peripheral blood NK cells from 5 sets of monozygotic twins and 12 unrelated donors of defined human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genotype. This analysis revealed a remarkable degree of NK cell diversity, with an estimated 6000 to 30,000 phenotypic populations within an individual and >100,000 phenotypes in the donor panel. Genetics largely determined inhibitory receptor expression, whereas activation receptor expression was heavily environmentally influenced. Therefore, NK cells may maintain self-tolerance through strictly regulated expression of inhibitory receptors while using adaptable expression patterns of activating and costimulatory receptors to respond to pathogens and tumors. These findings further suggest the possibility that discrete NK cell subpopulations could be harnessed for immunotherapeutic strategies in the settings of infection, reproduction, and transplantation.

Indexed as

EnvironmentAdultCluster AnalysisFemaleGene Expression RegulationHistocompatibility Antigens Class IHumansImmunologic MemoryKiller Cells, NaturalMaleMass SpectrometryMiddle AgedPhenotypeReceptors, Natural Killer CellYoung AdultHistocompatibility Antigens Class IReceptors, Natural Killer Cell

Identifiers

PMID24154599
PMCPMC3918221

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.